WATSON 698 200 (Hydroxychloroquine 200 mg)

Pill imprint WATSON 698 200 has been identified as Hydroxychloroquine sulfate 200 mg.

Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; undifferentiated connective tissue disease; sjogren's syndrome; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydroxychloroquine sulfate

Imprint:

WATSON 698 200

Strength:

200 mg

Color:

White

Size:

13.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antimalarial quinolines
Antirheumatics

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-0698

Inactive Ingredients:

silicon dioxide
dextrates
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol 8000
sodium starch glycolate type A potato
corn starch
titanium dioxide
triacetin
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0320	AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.